Beijing Science Sun Pharmaceutical Co., Ltd.
300485.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.73B
Close$
$0.57
92.7% downside
Current Fair Value
92.7% downsideOvervalued by 92.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.73 Billion |
|---|---|
| Enterprise Value | $3.70 Billion |
| Dividend Yield | $0.03 (0.39%) |
| Earnings per Share | $0.03 |
| Beta | 0.23 |
| Outstanding Shares | 481,666,400 |
Return
| Return on Equity | -5.51% |
|---|---|
| Return on Assets | -5.26% |
| Return on Invested Capital | -1.26% |
Valuation & Multiples
| P/E Ratio | -21.05 |
|---|---|
| PEG | 1.05 |
| Price to Sales | - |
| Price to Book Ratio | 1.29 |
| Enterprise Value to Revenue | 9.51 |
| Enterprise Value to EBIT | -89.32 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Beijing Science Sun Pharmaceutical Co., Ltd.
489 employees
CEO: Biao Ma Beijing Science Sun Pharmaceutical Co., Ltd. is a company, established in 1999 and headquartered in Beijing, China, that operates within the Chinese pharmaceutical market. It is dedicated to the research, development, manufacturing, and ...